PREVIEW

Slides 3 – 6 Unihealth Introduction, services & top

customers

Slides 7 – 16 Relevance of the new “iBreastExam”

introduced at Unihealth, first time in
Ahmedabad

Slides 17 – 22 Media engagement

Slides 23 – 26 Technology of iBreastExam, awards,

customers and partners
• First of its kind health concept in Gujarat

• Facilitating prediction, prevention and

pre-habilitation

• Advanced and innovative diagnostic

tools and technology

• Improved access and affordability

• Un-hospital like ambience

• Spread across 12,000 sq.ft

• Expert consultation

• Focus on corporate health and wellness

Early detection

Early intervention

Boost success of
treatment

Reduce treatment &

insurance costs

Reduce absenteeism

Improve job
performance

Improve quality of life

Our Top Customers
 Whats new !
Women prove themselves at work but …….. neglect health

UNIHEALTH calling WOMEN to take responsibility for their

BREAST HEALTH !

Business Head Center Head Breast Health Champions

Nobody is immune from breast cancer, not even ….the Super-Women

• Breast cancer ranks as the number ONE cancer among Indian females

• Breast cancer accounts for 25% to 32% of all female cancers in India

• Low survival rate as compared to the developed world

https://www.livemint.com/Science/UaNco9nvoxQtxjneDS4LoO/India-still-has-a-low-breast-cancer-survival-rate-of-66-st.html
http://www.breastcancerindia.net/statistics/trends.html

https://boingboing.net/2011/12/14/bse.html
Reasons for late detection
• Breast Health Check is not part of routine health check-up

• Some women are shy, others scared of outcome, most wrongly believe that if they don’t have
family history then they are not at risk

• Few women may go for self or clinical physical examination which may identify lumps in 50-
60% of cases only

• Most women go for mammography only when symptomatic, and on an average most
'symptomatic' cancers are stage 2B and beyond (significant numbers in stages 3 or 4)

• In the West, majority of breast cancers (read more than 75%) are detected early in
in stages 1 and 2 due to regular examination, resulting in good survival

• Generally mammography is recommended after 40 years of age for breast examination due to
exposure to radiation

• Some patients find mammography uncomfortable and painful if multiple positions and
pressure is required for a robust test depending on size and density of breast

http://www.breastcancerindia.net/statistics/trends.html
Lack of screening and late detection

Avg. age when diagnosed 43 - 46 Yr. 53 - 59 Yr.

% of cases detected late 60% - 75% 10%

5 Year survival rate 1/2 (50%) 1/10 (90%)

Climbing 2- Plateaued
Annual incidence rate 3%
% of women screened <1% 90%+
Young women falling prey to Breast Cancer

• Almost 48% patients are below 50

• An increasing numbers of patients are in the 25 to 50
years of age

http://www.breastcancerindia.net/statistics/trends.html
Regular Screening Modalities

I. Easily Accessible Screening

Modalities

a) Breast Self-Examination

b) Clinical Breast Examination

II. Advanced Modalities

a) Mammography

b) Ultrasound
I. b) Clinical Breast Examination

• Highly subjective

• Screening CBE has a sensitivity of about 54% Sensitivity means

the probability that test is positive when a lump is present

• Performance may vary based on the operator

II. a) Other limitations
per 4,000 people
1000 – 2500
per test
per 100,000 people
cost per mammogram
Radiologist
 Hence the need for an effective intermediate modality
https://www.facebook.com/Unihealth4All/videos/558351894598996/

 Painless & Radiation-Free

 Great for early detection

 Clinically effective in ALL

women, incl. dense breasts

 Highly Affordable

 Portable

 Sensitivity of 84% - better

than clinical breast
examination (refer annexure)

cleared
 Clinical Validation of iBreastExam
• Total 4 studies, 4000+ women enrolled
• Publications in IJGO April 2016 & WJSO Oct 2016
• Sensitivity of around 84% comparable to 91% of mammography hence
iBreastExam is recommended atleast once in a year
• Specificity of around 74% hence after getting a positive result of
iBreastExam, targeted USG is recommended followed by FNAC/Biopsy as
all lumps are not malignant. Same clinical pathway is followed after
Mammography also.
• iBreastExam sensitivity is 19% better than expert clinical breast
examination

Adobe Acrobat Adobe Acrobat

Document Document
 Media Engagement
RJ. EKTA inaugurates iBreastExam at Unihealth – 15th Sep 2018

https://www.instagram.com/p/Bn0j_9mHH0W/?hl=en&taken- https://www.instagram.com/p/Bnz2atAnhdV/?hl=en&taken-
by=ektainlove by=ektainlove
Ahmedabad Mirror - 17th Sep 2018
Social Media

https://youtu.be/PBW2XTUBc6s

https://youtu.be/WarbEhxj5UQ

https://m.facebook.com/Unihealth4All

https://www.linkedin.com/company/unihealth4all/
Radio Bites

- Morning, evening and afternoon every day on My FM and Mirchi Love

- Breast Cancer myths and facts

- FAQs

https://www.facebook.com/Unihealth4All/videos/2196005834022601/
https://www.facebook.com/Unihealth4All/videos/365165297550515/

- Real consumer interviews on radio with RJ. Ekta

https://www.facebook.com/Unihealth4All/videos/1888701614558235/
https://www.facebook.com/Unihealth4All/videos/683805475319425/

-Follow our FB page to stay abreast of new consumer interviews

added everyday and radio jingles
Hoardings and Bus Shelters across Ahmedabad
Group Offer @ just 299/-
Get your group of 10, take
the test at the comfort of
your home or group of 5 at
the Unihealth.
ANNEXURE
 Science & Technology
Piezoelectric Pressure Sensors
Proprietary, Patented Technology
WW IP license from Drexel U.
PC Board

Breast lesions are stiffer than normal breast tissue

Battery Contrast in elastic modulus is measurable
Detect changes in tissue stiffness difference
Sensor Array

Clinical Workflow
If +ve If +ve
iBreastExam ~1% of cancers
~5-7% ~7-10% confirmed

Targeted USG FNAC/Biopsy

 Key Technical Advisors Research Partners

Dr. R. A.
Mashelkar

Health Technology Dr. Kiran

Assessment by Mazumdar
WISH Foundation Shaw

Dr. Ravi
Mehrotra

1,50,000+ tests done

50+ cancers detected
Thank You